196 related articles for article (PubMed ID: 23610419)
1. Accumulation of the FACT complex, as well as histone H3.3, serves as a target marker for somatic hypermutation.
Aida M; Hamad N; Stanlie A; Begum NA; Honjo T
Proc Natl Acad Sci U S A; 2013 May; 110(19):7784-9. PubMed ID: 23610419
[TBL] [Abstract][Full Text] [Related]
2. FACT and H3.3: new markers for the somatic hypermutation.
Aida M; Honjo T
Cell Cycle; 2013 Sep; 12(18):2923-4. PubMed ID: 23974092
[No Abstract] [Full Text] [Related]
3. A role for the RNA pol II-associated PAF complex in AID-induced immune diversification.
Willmann KL; Milosevic S; Pauklin S; Schmitz KM; Rangam G; Simon MT; Maslen S; Skehel M; Robert I; Heyer V; Schiavo E; Reina-San-Martin B; Petersen-Mahrt SK
J Exp Med; 2012 Oct; 209(11):2099-111. PubMed ID: 23008333
[TBL] [Abstract][Full Text] [Related]
4. Histone3 lysine4 trimethylation regulated by the facilitates chromatin transcription complex is critical for DNA cleavage in class switch recombination.
Stanlie A; Aida M; Muramatsu M; Honjo T; Begum NA
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22190-5. PubMed ID: 21139053
[TBL] [Abstract][Full Text] [Related]
5. H3.Y discriminates between HIRA and DAXX chaperone complexes and reveals unexpected insights into human DAXX-H3.3-H4 binding and deposition requirements.
Zink LM; Delbarre E; Eberl HC; Keilhauer EC; Bönisch C; Pünzeler S; Bartkuhn M; Collas P; Mann M; Hake SB
Nucleic Acids Res; 2017 Jun; 45(10):5691-5706. PubMed ID: 28334823
[TBL] [Abstract][Full Text] [Related]
6. Identification of core DNA elements that target somatic hypermutation.
Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
[TBL] [Abstract][Full Text] [Related]
7. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
[TBL] [Abstract][Full Text] [Related]
8. The role of HIRA-dependent H3.3 deposition and its modifications in the somatic hypermutation of immunoglobulin variable regions.
Yu G; Zhang Y; Gupta V; Zhang J; MacCarthy T; Duan Z; Scharff MD
Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34873043
[TBL] [Abstract][Full Text] [Related]
9. Activation-induced cytidine deaminase an antibody diversification enzyme interacts with chromatin modifier UBN1 in B-cells.
Jaiswal A; Roy R; Tamrakar A; Singh AK; Kar P; Kodgire P
Sci Rep; 2023 Nov; 13(1):19615. PubMed ID: 37949972
[TBL] [Abstract][Full Text] [Related]
10. Role of Dot1L and H3K79 methylation in regulating somatic hypermutation of immunoglobulin genes.
Duan Z; Baughn LB; Wang X; Zhang Y; Gupta V; MacCarthy T; Scharff MD; Yu G
Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34253616
[TBL] [Abstract][Full Text] [Related]
11. What Targets Somatic Hypermutation to the Immunoglobulin Loci?
Heltzel JMH; Gearhart PJ
Viral Immunol; 2020 May; 33(4):277-281. PubMed ID: 31770070
[TBL] [Abstract][Full Text] [Related]
12. Histone modifications associated with somatic hypermutation.
Odegard VH; Kim ST; Anderson SM; Shlomchik MJ; Schatz DG
Immunity; 2005 Jul; 23(1):101-10. PubMed ID: 16039583
[TBL] [Abstract][Full Text] [Related]
13. The histone chaperone Spt6 is required for activation-induced cytidine deaminase target determination through H3K4me3 regulation.
Begum NA; Stanlie A; Nakata M; Akiyama H; Honjo T
J Biol Chem; 2012 Sep; 287(39):32415-29. PubMed ID: 22843687
[TBL] [Abstract][Full Text] [Related]
14. FACT facilitates chromatin transcription by RNA polymerases I and III.
Birch JL; Tan BC; Panov KI; Panova TB; Andersen JS; Owen-Hughes TA; Russell J; Lee SC; Zomerdijk JC
EMBO J; 2009 Apr; 28(7):854-65. PubMed ID: 19214185
[TBL] [Abstract][Full Text] [Related]
15. The DSIF subunits Spt4 and Spt5 have distinct roles at various phases of immunoglobulin class switch recombination.
Stanlie A; Begum NA; Akiyama H; Honjo T
PLoS Genet; 2012; 8(4):e1002675. PubMed ID: 22570620
[TBL] [Abstract][Full Text] [Related]
16. SRSF1-3, a splicing and somatic hypermutation regulator, controls transcription of IgV genes via chromatin regulators SATB2, UBN1 and histone variant H3.3.
Singh AK; Tamrakar A; Jaiswal A; Kanayama N; Kodgire P
Mol Immunol; 2020 Mar; 119():69-82. PubMed ID: 31986311
[TBL] [Abstract][Full Text] [Related]
17. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
[TBL] [Abstract][Full Text] [Related]
18. Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG.
Ehteda A; Simon S; Franshaw L; Giorgi FM; Liu J; Joshi S; Rouaen JRC; Pang CNI; Pandher R; Mayoh C; Tang Y; Khan A; Ung C; Tolhurst O; Kankean A; Hayden E; Lehmann R; Shen S; Gopalakrishnan A; Trebilcock P; Gurova K; Gudkov AV; Norris MD; Haber M; Vittorio O; Tsoli M; Ziegler DS
Cell Rep; 2021 Apr; 35(2):108994. PubMed ID: 33852836
[TBL] [Abstract][Full Text] [Related]
19. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
[TBL] [Abstract][Full Text] [Related]
20. Splicing regulator SRSF1-3 that controls somatic hypermutation of IgV genes interacts with topoisomerase 1 and AID.
Kumar Singh A; Tamrakar A; Jaiswal A; Kanayama N; Agarwal A; Tripathi P; Kodgire P
Mol Immunol; 2019 Dec; 116():63-72. PubMed ID: 31622795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
